Sign In
Buy APM
$1.09
+0.114 (+11.68%)
At Close: Jun 03, 2026
Andean Precious Metals Corp. (APM:CA) Q1 2026 Earnings Call Transcript
01:10pm, Wednesday, 13'th May 2026
Andean Precious Metals Corp. (APM:CA) Q1 2026 Earnings Call Transcript
Head-To-Head Survey: Aptorum Group (NASDAQ:APM) versus Catalyst Pharmaceuticals (NASDAQ:CPRX)
01:11am, Thursday, 16'th Apr 2026
Aptorum Group (NASDAQ: APM - Get Free Report) and Catalyst Pharmaceuticals (NASDAQ: CPRX - Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two b
Aptorum Group Limited (NASDAQ:APM) Short Interest Up 41.4% in March
01:29am, Tuesday, 14'th Apr 2026
Aptorum Group Limited (NASDAQ: APM - Get Free Report) saw a large growth in short interest during the month of March. As of March 31st, there was short interest totaling 12,292 shares, a growth of 41.
Prelude Therapeutics (NASDAQ:PRLD) vs. Aptorum Group (NASDAQ:APM) Critical Review
01:40am, Tuesday, 07'th Apr 2026
Aptorum Group (NASDAQ: APM - Get Free Report) and Prelude Therapeutics (NASDAQ: PRLD - Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the t
Andean Precious Metals Q4 Earnings Call Highlights
01:32am, Friday, 27'th Mar 2026
Andean Precious Metals (TSE: APM) used its fourth-quarter and year-end earnings call to highlight what management described as a "step change" in 2025 results, driven by record financial performance,
Andean Precious Metals Corp. (APM:CA) Q4 2025 Earnings Call Transcript
10:56am, Wednesday, 25'th Mar 2026
Andean Precious Metals Corp. (APM:CA) Q4 2025 Earnings Call Transcript
Aptorum Group Limited (NASDAQ:APM) Sees Significant Growth in Short Interest
03:16am, Wednesday, 18'th Mar 2026
Aptorum Group Limited (NASDAQ: APM - Get Free Report) was the target of a large increase in short interest during the month of February. As of February 27th, there was short interest totaling 11,553 s
NEW YORK, NY; NEW HAVEN, CT; and PRINCETON, NJ, March 10, 2026 (GLOBE NEWSWIRE) -- Aptorum Group Limited (NASDAQ: APM) ("Aptorum Group” or “Aptorum”), a clinical stage biopharmaceutical company
Aptorum Group Limited Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
04:30pm, Friday, 06'th Mar 2026
Hong Kong, March 06, 2026 (GLOBE NEWSWIRE) -- Aptorum Group Limited (NASDAQ: APM), a leading Biotechnology company, today announced that it has received a notification from the Nasdaq Stock Market LLC
NEW YORK, NY; NEW HAVEN, CT; PRINCETON, NJ, and TAIPEI, TAIWAN, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Aptorum Group Limited (NASDAQ: APM) ("Aptorum Group” or “Aptorum”), a clinical stage biopharmace
Short Interest in Aptorum Group Limited (NASDAQ:APM) Drops By 75.1%
03:52am, Wednesday, 14'th Jan 2026
Aptorum Group Limited (NASDAQ: APM - Get Free Report) saw a large decline in short interest during the month of December. As of December 31st, there was short interest totaling 2,681 shares, a decline
NEW YORK, NY, NEW HAVEN, CT, and PRINCETON, N.J., Nov. 19, 2025 (GLOBE NEWSWIRE) -- DiamiR Biosciences Corp. (“DiamiR”), a developer of innovative blood-based diagnostic tests for brain health and
Andean Precious Metals Corp. (APM:CA) Q3 2025 Earnings Call Transcript
11:21am, Wednesday, 12'th Nov 2025
Andean Precious Metals Corp. ( APM:CA ) Q3 2025 Earnings Call November 12, 2025 9:00 AM EST Company Participants Amanda Mallough Alberto Morales - Founder, CEO & Executive Chairman Yohann Bouchard - P
Aptorum Group Limited Announces Up To $6 Million Registered Direct Offering
09:54am, Friday, 10'th Oct 2025
$2 million upfront with up to additional $4 million of potential aggregate gross proceeds upon the exercise in full of warrants
As part of the planned merger with DiamiR Biosciences, Aptorum Group will expand its board and management team with seasoned executives
08:55am, Thursday, 09'th Oct 2025
NEW YORK, NY, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Aptorum Group Limited (NASDAQ: APM) ("Aptorum Group” or “Aptorum”), a clinical stage biopharmaceutical company dedicated to addressing unmet medic
